Valuation: Integra LifeSciences Holdings Corporation

Market Cap 139.21Cr 120.57Cr 112.39Cr 103.37Cr 195.15Cr 13TCr 197.33Cr 1.32TCr 518.39Cr 6.62TCr 522.86Cr 511.33Cr 22TCr P/E 2026 *
28x
P/E 2027 * 14.4x
Enterprise Value 288.15Cr 249.56Cr 232.64Cr 213.97Cr 403.93Cr 27TCr 408.45Cr 2.73TCr 1.07TCr 14TCr 1.08TCr 1.06TCr 45TCr EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.55x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-1.82%
1 week+6.46%
Current month+5.44%
1 month-3.44%
3 months+32.79%
6 months+61.35%
Current year+41.34%
1 week 16.24
Extreme 16.24
18.34
1 month 16.04
Extreme 16.04
20.49
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.65
5 years 8.7
Extreme 8.7
76.7
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap.
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
01/07/26 Free

Executive/Senior Manager

5,590 0.0072%
01/07/26 Free

Executive/Senior Manager

11,180 0.0144%
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%+6.46%+37.90%-61.36% 139.21Cr
-0.48%-2.97%-19.82%-3.37% 18TCr
-0.57%-2.15%-4.47%+1.11% 11TCr
+3.59%-0.58%+8.35%+69.77% 5.96TCr
-0.10%+9.35%+43.37%+59.19% 5.5TCr
-0.58%+0.42%-4.40%-38.56% 4.69TCr
-15.02%-11.71% - - 3.55TCr
-4.87%+9.58%+9.12%-31.93% 3.28TCr
+0.47%+3.86%+46.73%-7.45% 2.45TCr
-1.36%-2.06%+2.73%+1.68% 2.27TCr
Average -2.07%+2.66%+13.28%-1.21% 5.71TCr
Weighted average by Cap. -1.19%+1.52%+0.24%+7.16%

Financials

2026 *2027 *
Net sales 167.44Cr 145.02Cr 135.18Cr 124.33Cr 234.72Cr 16TCr 237.34Cr 1.59TCr 623.49Cr 7.97TCr 628.87Cr 615Cr 26TCr 172.8Cr 149.66Cr 139.51Cr 128.31Cr 242.24Cr 16TCr 244.94Cr 1.64TCr 643.46Cr 8.22TCr 649Cr 634.7Cr 27TCr
Net income 4.2Cr 3.64Cr 3.39Cr 3.12Cr 5.89Cr 399.68Cr 5.96Cr 40Cr 16Cr 199.98Cr 16Cr 15Cr 662.31Cr 7.87Cr 6.82Cr 6.35Cr 5.84Cr 11Cr 748.27Cr 11Cr 75Cr 29Cr 374.39Cr 30Cr 29Cr 1.24TCr
Net Debt 148.93Cr 128.99Cr 120.24Cr 110.59Cr 208.78Cr 14TCr 211.11Cr 1.41TCr 554.58Cr 7.09TCr 559.36Cr 547.03Cr 23TCr 128.49Cr 111.29Cr 103.74Cr 95Cr 180.13Cr 12TCr 182.14Cr 1.22TCr 478.47Cr 6.11TCr 482.59Cr 471.95Cr 20TCr
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
06/26/06 $17.56 -1.93% 3,07,468
04/26/04 $17.90 +0.11% 7,48,606
03/26/03 $17.88 +7.39% 12,78,776
31/26/31 $16.65 -2.75% 9,35,088
30/26/30 $17.12 +3.82% 17,07,650
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
17.90USD
Average target price
19.56USD
Spread / Average Target
+9.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock